Reduced Expression of E-cadherin and β-catenin and High Expression of Basal Cytokeratins in Feline Mammary Carcinomas With Regional Metastasis

Veterinary Pathology

Volumn 49, Issue 6, 2012, Pages 979-987

  Penafiel Verdu C ^a   Buendia, A J ^a   Navarro, J A ^a   Ramirez, G A ^b   Vilafranca, M ^b   Altimira, J ^b   Sanchez, J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b Histovet SL San Quirze del Valles   (Spain)

Author keywords

basal cytokeratins; E cadherin; feline mammary carcinoma; immunohistochemistry; catenin

Indexed keywords

BETA CATENIN; CADHERIN; KERATIN; TUMOR MARKER; VIMENTIN;

ADENOMA; ANIMAL; CANCER GRADING; CARCINOMA; CAT; CAT DISEASE; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; VETERINARY;

ADENOMA; ANIMALS; BETA CATENIN; CADHERINS; CARCINOMA; CAT DISEASES; CATS; FEMALE; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM GRADING; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84868694845     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985812436744     Document Type: Article

References (42)

1. Brunetti B,Sarli G,Preziosi R,et al.E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.Vet Pathol. 2005;42:781-787.
2. Burrai GP,Mohammed SI.Miller MA, et al.Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.BMC Cancer. 2010;10:156.
3. Castagnaro M,Casalone C.Bozzetta E, et al.Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas.J Comp Pathol. 1998;119:263-275.
4. Cowin P,Rowlands TM,Hatsell SJ.Cadherins and catenins in breast cancer.Curr Opin Cell Biol. 2005;17:499-508.
5. De Matos AJ,Lopes CC,Faustino AM,et al.E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours.APMIS. 2007;115:327-334.
6. Dias Pereira P,Gartner F.Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue.Vet Rec. 2003;153:297-302.
7. Elston CW,Ellis IO.Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.Histopathology. 1991;19:403-410.
8. Friedl P,Wolf K.Tumour-cell invasion and migration: diversity and escape mechanism.Nat Rev Cancer. 2003;3:362-374.
9. Gama A,Alves A,Schmitt F.Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification.Virchows Arch. 2008;453:123-132.
10. Gama A,Paredes J,Gärtner F,et al.Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.Vet J. 2008;177:45-53.
11. Hahn KA,Bravo L,Avenell JS.Feline breast carcinoma as a pathologic and therapeutic model for human breast cancer.In Vivo. 1994;8:825-828.
12. Klopfleisch R,von Euler H,Sarli G,et al.Molecular carcinogenesis of canine mammary tumors: news from an old disease.Vet Pathol. 2011;48:98-116.
13. Korsching E,Jeffrey SS,Meinerz W,et al.Basal carcinoma of the breast revisited: an old entity with new interpretations.J Clin Pathol. 2008;61:553-560.
14. Korsching E,Packeisen J,Liedtke C,et al.The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilineal differentiation potential?.J Pathol. 2005;206:451-457.
15. Livasy CA,Perou CM,Karaca G,et al.Identification of a basal-like subtype of breast ductal carcinoma in situ.Hum Pathol. 2007;38:197-204.
16. MacEwen EG,Hayes AA,Harvey HJ,et al.Prognostic factors for feline mammary tumors.J Am Vet Med Assoc. 1984;2:201-204.
17. Maeda M,Johnson KR,Wheelock MJ.Cadherin switching: essential for behavioral but not morphological changes during a epithelium-to-mesenchyme transition.J Cell Sci. 2005;118:873-997.
18. Martin de las,Mulas J,Espinosa de los,Monteros A,Bautista MJ,et al.Immunohistochemical distribution pattern of intermediate filament proteins and muscle actin in feline and human mammary carcinomas.J Comp Pathol. 1994;111:365-381.
19. Martin de las,Mulas J,Van Niel N,Millan Y,et al.Progesterone receptors in normal, dysplastic and tumorous feline mammary glands. Comparison with oestrogen receptors status.Res Vet Sci. 2002;72:153-161.
20. Matos AJ,Faustino AM,Lopes C,et al.Detection of lymph node micrometastasis in malignant mammary tumours in dogs by cytokeratin immunostaining.Vet Rec. 2006;158:626-630.
21. Millanta F,Callandrela M,Bari G,et al.Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.Res Vet Sci. 2005;79:225-232.
22. Millanta F,Calandrella M,Citi S,et al.Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.Vet Pathol. 2005;42:30-34.
23. Millanta F,Callandrela M,Vannozzi I,et al.Steroid hormone receptors in normal dysplastic and neoplastic feline mammary tissues and their prognostic significance.Vet Rec. 2006;158:821-824.
24. Misdorp WTumors in Domestic Animals. 4th ed. Ames, IA: Iowa Press; 2002:575-605.Meuten DJ, ed. Ames, IA: Iowa Press; 2002:575-605.
25. Nielsen TO,Hsu FD,Jensen K,et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.Clin Cancer Res. 2004;10:5367-5374.
26. Ordás J,Millán Y,Dios R,et al.Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study.BMC Cancer. 2007;7:179.
27. Peppercorn J,Perou CM,Carey LA.Molecular subtypes in breast cancer evaluation and management: divide and conquer.Cancer Invest. 2008;26:1-10.
28. Perou CM,Sørlie T,Eisen MB,et al.Molecular portraits of human breast tumours.Nature. 2000;406:747-752.
29. Rakha EA,El-Sayed ME,Green AR,et al.Breast carcinoma basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.Histopathology. 2007;50:434-438.
30. Rakha EA,Patel A,Powe DG,et al.Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.Am J Surg Pathol. 2010;34:1472-1479.
31. Rasotto R,Caliari D,Castagnaro M,et al.An immunohistochemical study of HER-2 expression in feline mammary tumours.J Comp Pathol. 2011;144:170-179.
32. Sanchez J,Ramirez GA,Buendia AJ,et al.Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.Vet Pathol. 2007;44:676-682.
33. Sarli G,Brunetti Benazzi C.Mammary mucinous carcinoma in the cat.Vet Pathol. 2006;43:667-673.
34. Sarrio D,Rodriguez-Pinilla SM,Hardisson D,et al.Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.Cancer Res. 2008;68:989-997.
35. Sassi F,Benazzi C,Castellani G,et al.Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry.BMC Vet Res. 2010;6:5.
36. Seixas F,Palmeira C,Pires MA,et al.Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis.Vet J. 2011;187:65-71.
37. Shackleton M,Vaillant F,Simpson KJ,et al.Generation of a functional mammary gland from a single stem cell.Nature. 2006;439:84-88.
38. Takauji SR,Watanabe M,Uyama R,et al.Expression and subcellular localization of E-cadherin, alpha-catenin, and beta-catenin in 8 feline mammary tumor cell lines.J Vet Med Sci. 2007;69:831-834.
39. Thiery JP,Acloque H,Huang RY,et al.Epithelial-mesenchymal transitions in development and disease.Cell. 2009;139:871-890.
40. Tomaskovic-Crook E,Thompson EW,Thiery JP.Epithelial-mesenchymal transition and breast cancer.Breast Cancer Res. 2009;11:213.
41. Winston J,Craft DM,Scase TJ,et al.Immunohistochemical detection of HER-2/neu expression in spontaneous feline mammary tumours.Vet Comp Oncol. 2005;3:8-15.
42. Zappulli Z,De Zan G,Cardazzo B,et al.Feline mammary tumours in comparative oncology.J Dairy Res. 2005;72:98-106.